Brokerage firms have identified eight stocks with potential upside of upto 50%. Here is the list of the stocks:
Dr Reddy’s Laboratories (24.8% upside) : JM Financial has a ‘Buy’ rating with a target price of Rs 1,545, citing strong growth in India and emerging markets.
Mphasis (21.3% upside) : JM Financial has a ‘Buy’ rating with a target price of Rs 3,330, highlighting strong traction in BFSI and AI-led deal wins.
-KEI Industries (36.1% upside) : JM Financial has a ‘Buy’ rating with a target price of Rs 5,200, citing margin expansion and strong revenue growth.
-Waaree Energies (49.6% upside) : Nomura has a ‘Buy’ rating with a target price of Rs 3,890, highlighting order book strength and capacity expansion.
United Spirits (23% upside) : Nomura has a ‘Buy’ rating with a target price of Rs 1,650, citing long-term premiumisation potential.
Tata Communications (45.2% upside): JM Financial has a ‘Buy’ rating with a target price of Rs 2,250, highlighting steady data growth and improving profitability.
Zee Entertainment Enterprises (34.5% upside) : JM Financial has a ‘Buy’ rating with a target price of Rs 110, citing improvement in digital profitability.
Glenmark Pharma (17% upside) : Choice Institutional Equities has a ‘Buy’ rating with a target price of Rs 2,235.